Thus, it can be assumed that the increase in PTGS2 expression that we observed in patients with early stages of PD indicates the development of inflammatory processes, which is likely to lead to even greater death of DAergic neurons and, thereby, enhance neurodegeneration. This evidence concerns the gene PTGS2 and Parkinson disease.